Impaired effect of endothelin-1 on coronary artery stiffness in type 2 diabetes.

[1]  J. Panza,et al.  Increased Activity of Endogenous Endothelin in Patients With Type II Diabetes Mellitus , 2002, Circulation.

[2]  D. Webb,et al.  Acute endothelin(A) receptor antagonism improves coronary artery compliance in coronary artery disease patients. , 2002, Clinical science.

[3]  A. Jeremias,et al.  Coronary artery distensibility and compensatory vessel enlargement – a novel parameter influencing vascular remodeling? , 2001, Basic Research in Cardiology.

[4]  A. Jeremias,et al.  Coronary artery compliance and adaptive vessel remodelling in patients with stable and unstable coronary artery disease , 2000, Heart.

[5]  G. D. Johnston,et al.  Vasoconstriction to endogenous endothelin-1 is impaired in patients with type II diabetes mellitus. , 2000, Clinical science.

[6]  D. Webb,et al.  Endogenous endothelin maintains coronary artery tone by endothelin type A receptor stimulation in patients undergoing coronary arteriography , 2000, Heart.

[7]  G. D. Johnston,et al.  Vasoconstriction to endothelin-1 is blunted in non-insulin-dependent diabetes: a dose-response study. , 2000, Journal of cardiovascular pharmacology.

[8]  C. Stefanadis,et al.  Coronary artery distensibility in diabetic patients with simultaneous measurements of luminal area and intracoronary pressure: evidence of impaired reactivity to nitroglycerin. , 1999, Journal of the American College of Cardiology.

[9]  M. Grigioni,et al.  Endothelin and mechanical properties of the carotid artery in Wistar-Kyoto and spontaneously hypertensive rats. , 1999, Cardiovascular research.

[10]  G. D. Johnston,et al.  Impaired Vasoconstriction to Endothelin 1 in Patients With NIDDM , 1996, Diabetes.

[11]  D. Owens,et al.  Impact of initial treatment on renal function in newly-diagnosed Type 2 (non-insulin-dependent) diabetes mellitus , 1993, Diabetologia.

[12]  D. Webb,et al.  The endothelin family of peptides: local hormones with diverse roles in health and disease? , 1993, Clinical science.

[13]  W. Hodgson,et al.  Effects of glucose, insulin or aldose reductase inhibition on responses to endothelin‐1 of aortic rings from streptozotocin‐induced diabetic rats , 1992, British journal of pharmacology.

[14]  J. Ritter,et al.  Vascular responsiveness and cation exchange in insulin-dependent diabetes. , 1991, Clinical science.

[15]  L. M. Aiello,et al.  Vascular Reactivity to Angiotensin II and to Norepinephrine in Diabetic Subjects , 1976, Diabetes.

[16]  D. Archer,et al.  Altered endothelin-1 induced contraction and second messenger generation in bovine retinal microvascular pericytes cultured in high glucose medium , 2004, Diabetologia.

[17]  F. Goebel,et al.  Determination of endothelin-1 immunoreactivity in plasma, cerebrospinal fluid and urine , 1994, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.

[18]  T. Fukami,et al.  Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. , 1992, Life sciences.